home.aspx
 
. https://pharmaceutical.report/Resources/Whitepapers/e01986ff-a44b-42c6-b946-f92acccc206a_Physician Payment Sunshine Act & ESignatures.pdf
whitepaper
SHARESHARESHARE
THE PHYSICIAN PAYMENT SUNSHINE ACT AND ESIGNATURES - ACHIEVING SUSTAINABLE COMPLIANCE
Applicable pharmaceutical and medical device manufacturers could face fines up to $1.15 million annually for failing to correctly report payments made to physicians, as mandated in the Transparency Reports and Reporting of Physician Ownership or Investment Interests section of the Patient Protection and Affordable Care Act, commonly referred to as the “Physician Payment Sunshine Act.” Although the Act’s writers and prominent figures within the healthcare industry have urged for swift adoption, final approval was just released February 1, 2013 – one full year after the public comment period closed. The industry has been abuzz, trying to identify best practices in aiming their processes and technologies for what is finally a confirmed, albeit ambiguous, target. DOWNLOAD